Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.

Researchers have created nanoparticles that can remove disease-driving proteins while also delivering a chemotherapeutic or ...

Company leaders to engage the global research community on circular RNA, AI-driven therapeutics, and next-generation ...

A single intramuscular injection of a self-amplifying RNA therapy produced weeks of heart-protective protein in rat models of myocardial infarction, according to a study published in Science on March ...

Abstract: At present, optical fiber surface plasmon resonance (SPR) biosensing technology faces two significant challenges, enhancing the detection performance and expanding the detected target types.

Scientists developed "nano-origami" using DNA, gold nanoparticles to reshape droplets into six-pointed stars, enabling programmable molecular shape-shifting.

Liberate Bio, Inc., a biotechnology company developing genetic medicines that deliver RNA therapies directly to immune cells, announces that it has secured exclusive and non-exclusive licenses to key ...

A newly published Perspective article in Nature Nanotechnology details groundbreaking nanoparticle technology to eliminate harmful, disease-causing proteins in the body. The technology marks a ...

Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable to perform their roles properly due to suppression by the tumor. A KAIST ...